Oxalic Acid

Oxalic Acid

SCHEMBL3540727

Cl.Cl.Cl.O=C(O)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL3541670 1.00 CA1 (0.50)
Oxalic Acid SCHEMBL3549296 1.00 CA1 (0.50)
Oxalic Acid SCHEMBL3282497 1.00
Oxalic Acid SCHEMBL936463 1.00
Oxalic Acid SCHEMBL9701492 1.00 CA1 (0.50)
Oxalic Acid SCHEMBL3543377 1.00 CA1 (0.50)
Oxalic Acid SCHEMBL3585690 0.94
Oxalic Acid SCHEMBL3588735 0.94
Oxalic Acid SCHEMBL3585143 0.94
Oxalic Acid SCHEMBL15845120 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799799-B2 Indolizine derivatives, method for preparing same, and therapeutic compositions comprising same SANOFI-AVENTIS (FR) 2010-09-21 US disclosed
US-20080287485-A1 NOVEL INDOLIZINE DERIVATIVES, METHOD FOR PREPARING SAME, AND THERAPEUTIC COMPOSITIONS COMPRISING SAME SANOFI-AVENTIS (FR) 2008-11-20 US disclosed
CN-101175748-A N, N-substituted 3-aminopyrrolidine compounds useful as monoamine reuptake inhibitors OTSUKA PHARMA CO LTD (JP) 2008-05-07 CN disclosed